# Northwest Biotherapeutics Inc: Form 8-K, filed May 2, 2024

- Company: [Northwest Biotherapeutics Inc](/companies/nwbo.md) (CIK 1072379)
- Form: 8-K
- Filed: 2024-05-02
- Accepted by EDGAR: May 2, 2024, 16:39 ET
- Period: 2024-04-26
- Accession: 0001104659-24-056424
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1072379/000110465924056424/tm2413348d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1072379/000110465924056424/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1072379/000110465924056424/tm2413348d1_8k.htm

Filed May 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-056424. Last ingested by Listed: Oct 30, 2026, 16:18 ET. No prices; not investment advice.